Full text
PDF





Selected References
These references are in PubMed. This may not be the complete list of references from this article.
- Bower A., Hadley M. E., Hruby V. J. Comparative MSH release-inhibiting activities of tocinoic acid (the ring of oxytocin), and L-pro-L-leu-gly-NH 2 (the side chain of oxytocin). Biochem Biophys Res Commun. 1971 Dec 3;45(5):1185–1191. doi: 10.1016/0006-291x(71)90143-4. [DOI] [PubMed] [Google Scholar]
- Celis M. E., Hase S., Walter R. Structure-activity studies of MSH-release-inhibiting hormone. FEBS Lett. 1972 Nov 1;27(2):327–330. doi: 10.1016/0014-5793(72)80651-3. [DOI] [PubMed] [Google Scholar]
- Celis M. E., Taleisnik S., Walter R. Regulation of formation and proposed structure of the factor inhibiting the release of melanocyte-stimulating hormone. Proc Natl Acad Sci U S A. 1971 Jul;68(7):1428–1433. doi: 10.1073/pnas.68.7.1428. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Celis M. E., Taleisnik S., Walter R. Release of pituitary melanocyte-stimulating hormone by the oxytocin fragment, H-Cys-Tyr-Ile-Gln-Asn-Oh. Biochem Biophys Res Commun. 1971 Nov 5;45(3):564–569. doi: 10.1016/0006-291x(71)90454-2. [DOI] [PubMed] [Google Scholar]
- Hruby V. J., Smith C. W., Bower A., Hadley M. E. Melanophore stimulating hormone: release inhibition by ring structures of neurohypophysial hormones. Science. 1972 Jun 23;176(4041):1331–1332. doi: 10.1126/science.176.4041.1331. [DOI] [PubMed] [Google Scholar]
- Kastin A. J., Barbeau A. Preliminary clinical studies with L-prolyl-L-leucyl-glycine amide in Parkinson's disease. Can Med Assoc J. 1972 Dec 9;107(11):1079–1081. [PMC free article] [PubMed] [Google Scholar]
- Kastin A. J., Miller M. C., Ferrell L., Schally A. V. General activity in intact and hypophysectomized rats after administration of melanocyte-stimulating hormone (MSH), melatonin, and PRO-LEU-GLY-NH 2 . Physiol Behav. 1973 Feb;10(2):399–401. doi: 10.1016/0031-9384(73)90330-2. [DOI] [PubMed] [Google Scholar]
- Kastin A. J., Schally A. V. In vivo assay for melanocyte lightening substances. Experientia. 1966 Jun 15;22(6):389–389. doi: 10.1007/BF01901154. [DOI] [PubMed] [Google Scholar]
- Kastin A. J., Schally A. V., Viosca S. Inhibition of MSH release in frogs by direct application of L-proplyl-L-leucylglycinamide to the pituitary. Proc Soc Exp Biol Med. 1971 Sep;137(4):1437–1439. doi: 10.3181/00379727-137-35805. [DOI] [PubMed] [Google Scholar]
- Lapin I. P., Oxenkrug G. F., Osipova S. V., Uskova N. V. The frog as a subject for screening thymoleptic drugs. J Pharm Pharmacol. 1970 Oct;22(10):781–782. doi: 10.1111/j.2042-7158.1970.tb08429.x. [DOI] [PubMed] [Google Scholar]
- Nair R. M., Kastin A. J., Schally A. V. Isolation and structure of another hypothalamic peptide possessing MSH-release-inhibiting activity. Biochem Biophys Res Commun. 1972 Jun 28;47(6):1420–1425. doi: 10.1016/0006-291x(72)90231-8. [DOI] [PubMed] [Google Scholar]
- Nair R. M., Kastin A. J., Schally A. V. Isolation and structure of hypothalamic MSH release-inhibition hormone. Biochem Biophys Res Commun. 1971 Jun 18;43(6):1376–1381. doi: 10.1016/s0006-291x(71)80026-8. [DOI] [PubMed] [Google Scholar]
- Plotnikoff N. P., Kastin A. J., Anderson M. S., Schally A. V. DOPA potentiation by a hypothalamic factor, MSH release-inhibiting hormone (MIF). Life Sci I. 1971 Nov 15;10(22):1279–1283. doi: 10.1016/0024-3205(71)90326-2. [DOI] [PubMed] [Google Scholar]
- Plotnikoff N. P., Kastin A. J., Anderson M. S., Schally A. V. Deserpidine antagonism by a tripeptide, L-prolyl-L-leucyglycinamide. Neuroendocrinology. 1973;11(1):67–71. doi: 10.1159/000122119. [DOI] [PubMed] [Google Scholar]
- Plotnikoff N. P., Kastin A. J., Anderson M. S., Schally A. V. Oxotremorine antagonism by a hypothalamic hormone, melanocyte-stimulating hormone release-inhibiting factor (MIF). Proc Soc Exp Biol Med. 1972 Jul;140(3):811–814. doi: 10.3181/00379727-140-36558. [DOI] [PubMed] [Google Scholar]
- Schally A. V., Kastin A. J. Purification of a bovine hypothalamic factor which elevates pituitary MSH levels in rats. Endocrinology. 1966 Oct;79(4):768–772. doi: 10.1210/endo-79-4-768. [DOI] [PubMed] [Google Scholar]
